Combining our in vitro findings with the previous data, it would be reasonable to suggest that GAS5 silencing may suppress IL-1β-induced NPC apoptosis and ECM degradation through the miR-17-3p/Ang-2 axis. The gene discussed is GAS5; the disease is nasopharyngeal carcinoma.